Pasar al contenido principal

REPROGRAMACION TRANSCRIPCIONAL DEL RECEPTOR NUCLEAR LXRALFA Y EL CONTROL DE LA IDENTIDAD DE LOS MACROFAGOS EN HOMEOSTASIS E INFLAMACION

PID2022-137696OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Endogenous LXR signaling controls pulmonary surfactant homeostasis and prevents lung inflammation

  • Hernández-Hernández, Irene
  • De La Rosa, Juan V.
  • Martín-Rodríguez, Patricia
  • Díaz-Sarmiento, Mercedes
  • Recio, Carlota
  • Guerra, Borja
  • Fernández-Pérez, Leandro
  • León, Theresa E.
  • Torres Blanch, Rosa|||0000-0002-9109-4035
  • Font-Díaz, Joan|||0000-0002-7686-2278
  • Roig, Angela
  • Mora Pérez, Fernando de|||0000-0002-3002-6004
  • Boscá, Lisardo|||0000-0002-0253-5469
  • Díaz, Mario
  • Valledor, Annabel F.|||0000-0003-4232-2633
  • Castrillo, Antonio|||0000-0002-2057-2159
  • Tabraue, Carlos|||0000-0001-9920-8116
The online version contains supplementary material available at 10.1007/s00018-024-05310-3.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Reprogramming of the LXRα Transcriptome Sustains Macrophage Secondary Inflammatory Responses

  • Rosa, Juan V. de la
  • Tabraue, Carlos
  • Huang, Zhiqiang
  • Orizaola, Marta C.
  • Martín-Rodríguez, Patricia
  • Steffensen, Knut R.
  • Zapata, Juan M.
  • Boscá, Lisardo
  • Tontonoz, Peter
  • Alemany, Susana
  • Treuter, Eckardt
  • Castrillo, Antonio
Macrophages regulate essential aspects of innate immunity against pathogens. In response to microbial components, macrophages activate primary and secondary inflammatory gene programs crucial for host defense. The liver X receptors (LXRα, LXRβ) are ligand-dependent nuclear receptors that direct gene expression important for cholesterol metabolism and inflammation, but little is known about the individual roles of LXRα and LXRβ in antimicrobial responses. Here, the results demonstrate that induction of LXRα transcription by prolonged exposure to lipopolysaccharide (LPS) supports inflammatory gene expression in macrophages. LXRα transcription is induced by NF-κB and type-I interferon downstream of TLR4 activation. Moreover, LPS triggers a reprogramming of the LXRα cistrome that promotes cytokine and chemokine gene expression through direct LXRα binding to DNA consensus sequences within cis-regulatory regions including enhancers. LXRα-deficient macrophages present fewer binding of p65 NF-κB and reduced histone H3K27 acetylation at enhancers of secondary inflammatory response genes. Mice lacking LXRα in the hematopoietic compartment show impaired responses to bacterial endotoxin in peritonitis models, exhibiting reduced neutrophil infiltration and decreased expansion and inflammatory activation of recruited F4/80lo-MHC-IIhi peritoneal macrophages. Together, these results uncover a previously unrecognized function for LXRα-dependent transcriptional cis-activation of secondary inflammatory gene expression in macrophages and the host response to microbial ligands., This work was supported by grants from Ministerio de Ciencia, Innovación y Fondo Europeo de Desarrollo Regional (FEDER), Agencia Estatal de Investigación Grant Refs: PID2019-104284RB-I00 and PID2022-137696OB-I00 funded by 10.13039/501100011033 and, by “ERDF A way of making Europe”, by the “European Union” or by the “European Union NextGenerationEU/PRTR” to AC and support from Networks of Excellence from MINECO (Nuclear Receptors in Cancer, Metabolism and Inflammation [NuRCaMeIn] SAF2017-90604-REDT to AC. Z.H. was supported by a Lilly Young Investigator Award (97081) from the European Foundation for the Study of Diabetes (EFSD). E.T. was supported by grants from the Swedish Research Council (2022-00545), the Swedish Cancer Society (2021/1582) and the Novo Nordisk Foundation (NNF21OC0070256 and NNF22OC0078222)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Potential Beneficial Role of Nitric Oxide in SARS-CoV-2 Infection: Beyond Spike-Binding Inhibition

  • Sánchez-García, Sergio
  • Castrillo, Antonio
  • Boscá, Lisardo
  • Prieto, Patricia
SARS-CoV-2, the causative virus for the COVID-19 disease, uses its spike glycoprotein to bind to human ACE2 as a first step for viral entry into the cell. For this reason, great efforts have been made to find mechanisms that disrupt this interaction, avoiding the infection. Nitric oxide (NO) is a soluble endogenous gas with known antiviral and immunomodulatory properties. In this study, we aimed to test whether NO could inhibit the binding of the viral spike to ACE2 in human cells and its effects on ACE2 enzymatic activity. Our results show that ACE2 activity was decreased by the NO donors DETA-NONOate and GSNO and by the NO byproduct peroxynitrite. Furthermore, we found that DETA-NONOate could break the spike-ACE2 interaction using the spike from two different variants (Alpha and Gamma) and in two different human cell types. Moreover, the same result was obtained when using NO-producing murine macrophages, while no significant changes were observed in ACE2 expression or distribution within the cell. These results support that it is worth considering NO as a therapeutic agent for COVID-19, as previous reports have suggested., This research was funded by PID2023-148933OB-I00 and PID2022-137696OB-I00 from MICIN/AEI 13039/501100011033 and the Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CB16/11/00222) from the Instituto de Salud Carlos III (co-financed by the European Development Regional Fund “A Way to Achieve Europe”, by the “European Union” and by the “European Union NextGeneration EU/PRTR”), Comunidad de Madrid, Programa Biociencias (S2022-BMD-7223). We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Endogenous LXR signaling controls pulmonary surfactant homeostasis and prevents lung inflammation

  • Hernández-Hernández, Irene
  • Rosa, Juan V. de la
  • Martín-Rodríguez, Patricia
  • Díaz-Sarmineto, Mercedes
  • Recio, Carlota
  • Guerra, Borja
  • Fernández-Pérez, Leandro
  • León, Theresa E.
  • Torres, Rosa
  • Font-Díaz, Joan
  • Roig, Ángela
  • Mora, Fernando de
  • Boscá, Lisardo
  • Díaz, Mario
  • Valledor, Annabel F.
  • Castrillo, Antonio
Lung type 2 pneumocytes (T2Ps) and alveolar macrophages (AMs) play crucial roles in the synthesis, recycling and catabolism of surfactant material, a lipid/protein fluid essential for respiratory function. The liver X receptors (LXR), LXRα and LXRβ, are transcription factors important for lipid metabolism and inflammation. While LXR activation exerts anti-inflammatory actions in lung injury caused by lipopolysaccharide (LPS) and other inflammatory stimuli, the full extent of the endogenous LXR transcriptional activity in pulmonary homeostasis is incompletely understood. Here, using mice lacking LXRα and LXRβ as experimental models, we describe how the loss of LXRs causes pulmonary lipidosis, pulmonary congestion, fibrosis and chronic inflammation due to defective de novo synthesis and recycling of surfactant material by T2Ps and defective phagocytosis and degradation of excess surfactant by AMs. LXR-deficient T2Ps display aberrant lamellar bodies and decreased expression of genes encoding for surfactant proteins and enzymes involved in cholesterol, fatty acids, and phospholipid metabolism. Moreover, LXR-deficient lungs accumulate foamy AMs with aberrant expression of cholesterol and phospholipid metabolism genes. Using a house dust mite aeroallergen-induced mouse model of asthma, we show that LXR-deficient mice exhibit a more pronounced airway reactivity to a methacholine challenge and greater pulmonary infiltration, indicating an altered physiology of LXR-deficient lungs. Moreover, pretreatment with LXR agonists ameliorated the airway reactivity in WT mice sensitized to house dust mite extracts, confirming that LXR plays an important role in lung physiology and suggesting that agonist pharmacology could be used to treat inflammatory lung diseases., This work was supported by grants from the Ministerio de Ciencia, Innovación y Fondo Europeo de Desarrollo Regional (FEDER), Agencia Estatal de Investigación grants PID2019-104284RB-I00, PID2022-137696OB-I00 funded by 10. 13039/501100011033 to AC and CT, grants PID2020-119875RB-I00 and SAF2017-89510-R to AFV and SAF2017-90604-REDT to the NuRCaMeIn network, grant PI18/01702 to FdM from the Instituto de Salud Carlos III and grant PROID2017010050 to CT from the Agencia Canaria de Investigación, Innovación y Sociedad de la Información (ACIISI). IHH and JFD received FPI predoctoral fellowships from the Spanish Ministerio de Ciencia, Innovación y Universidades (PRE2018-085579 to JFD and BES2009012191 to IHH)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Modulation of the K/BxN arthritis mouse model and the effector functions of human fibroblast-like synoviocytes by liver X receptors

  • Domínguez-Luis, María Jesús
  • Castro-Hernández, Javier
  • Santos-Concepción, Jorge
  • Díaz-Martín, Ana
  • Arce-Franco, Mayte
  • Pérez-González, Natán
  • Díaz, Mercedes
  • Castrillo, Antonio
  • Salido, Eduardo
  • Machado, José David
  • Guma, Mónica
  • Corr, Maripat
  • Díaz-González, Federico
The role of liver X receptors (LXR) in rheumatoid arthritis (RA) remains controversial. We studied the effect of LXR agonists on fibroblast-like synoviocytes (FLS) from RA patients and the K/BxN arthritis model in LXRα and β double-deficient (Nr1h2/3−/−) mice. Two synthetic LXR agonists, GW3965 and T0901317, were used to activate LXRs and investigate their effects on cell growth, proliferation and matrix metalloproteinases, and chemokine production in cultured FLS from RA patients. The murine model K/BxN serum transfer of inflammatory arthritis in Nr1h2/3−/− animals was used to investigate the role of LXRs on joint inflammation in vivo. LXR agonists inhibited the FLS proliferative capacity in response to TNF, the chemokine-induced migration, the collagenase activity in FLS supernatant and FLS CXCL12 production. In the K/BxN mouse model, Nr1h2/3−/− animals showed aggravated arthritis, histological inflammation, and joint destruction, as well as an increase in synovial metalloproteases and expression of proinflammatory mediators such as IL-1β and CCL2 in joints compared with wild type animals. Taken together, these data underscore the importance of LXRs in modulating the joint inflammatory response and highlight them as potential therapeutic targets in RA., This work was supported by Asociación para la ayuda a la Investigación en ReumatologíaHospital Universitario de Canarias del (REUNINVES) and Instituto de Salud Carlos III PI12/02499 and PI21/00406 to F. D-G; and Spanish Ministry of Science and Education: PID2019-104284RB-I00/MCIN/AEI/10.13039/501100011033 and PID2022-137696OB-I00/MCIN/AEI/10.13039/501100011033 by “ERDF A way of making Europe”, by the “European Union” to A.C., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Liver X Receptors and Inflammatory-Induced C/EBPβ Selectively Cooperate to Control CD38 Transcription

  • Glaria, Estibaliz
  • Rodríguez Martínez, Pol
  • Font-Díaz, Joan
  • Rosa, Juan V. de la
  • Castrillo, Antonio
  • Crawshaw, Dylan J.
  • Vidal Taboada, Jose Manuel
  • Saura, Josep
  • Matalonga, Jonathan
  • Chini, Eduardo N.
  • Caelles, Carme
  • Valledor, Annabel F.
[Introduction] Macrophages abundantly express liver X receptors (LXRs), which are ligand-dependent transcription factors and sensors of several cholesterol metabolites. In response to agonists, LXRs promote the expression of key lipid homeostasis regulators. Cross talk between LXRs and inflammatory signals exists in a cell type- and gene-specific manner. A common feature in the macrophage response to inflammatory mediators is the induction of CCAAT/enhancer-binding protein beta (C/EBPβ), a master transcriptional regulator and lineage-determining transcription factor in monocytes/macrophages., [Methods] Quantitative real-time PCR in control and C/EBPβ-deficient macrophages was used to explore the role of C/EBPβ in the cross talk between inflammatory mediators and the macrophage response to pharmacological LXR activation. The functional interaction between C/EBPβ and LXRs on selected genomic regions was further characterized by chromatin-immunoprecipitation (ChIP) and gene reporter studies., [Results] Whereas inflammatory signaling repressed several LXR-regulated genes involved in lipid metabolism, these effects were conserved after deletion of C/EBPβ. In contrast, inflammatory mediators and LXRs synergistically induced the expression of the multifunctional protein CD38 in a C/EBPβ-dependent manner. C/EBPβ and LXRs bound to several regions with enhancer activity upstream and within the mouse Cd38 gene and their functional cooperation in macrophages required intact binding sites for LXR and C/EBPβ., [Conclusion] This study reveals positive cross talk between C/EBPβ and LXRs during the macrophage inflammatory response, which selectively impacts CD38 expression., This work was supported by Grants SAF2017-89510-R and PID2020-119875RB-I00 to A.F.V. and C.C., PID2022-137696OB-I00 to A.C., and SAF2017-90604-REDT and SAF2015-71878-REDT to the NuRCaMeIn network, funded by MICIU/AEI/10.13039/501100011033 and by ERDF A way of making Europe; grants 201605.30 to A.F.V. and 201605.31 to C.C. funded by Fundació La Marató de TV3; grants PI14/302 to J.S., and PI19/0593 and PI23/0850 to J.M.V.T., funded by Instituto de Salud Carlos III and by ERDF/EU A way to make Europe; grant from Fundación Luzón (Programa de Ayudas para Proyectos de Investigación en ELA Unzué-Luzón 2024) to J.M.V.T.; grants 2021SGR01433 and 2021SGR01121 from AGAUR-Generalitat de Catalunya to A.F.V. and J.M.V.T., respectively; and the European Cooperation in Science and Technology (COST) Actions BM1404 Mye-EUNITER and CA20117 Mye-InfoBank. E.G. received a fellowship from the University of Barcelona (APIF). J.F.D. and J.M. received fellowships PRE2018-085579 and BES-2009-014828, respectively, funded by MICIU/AEI/10.13039/501100011033 and by FSE invests in your future., Peer reviewed